{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:30:03Z","timestamp":1763141403717},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,12]]},"DOI":"10.7759\/cureus.9684","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T12:33:51Z","timestamp":1597235631000},"source":"Crossref","is-referenced-by-count":5,"title":["Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases"],"prefix":"10.7759","author":[{"given":"Amirseena","family":"Tolebeyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oranus","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.7.4.317","article-title":"Bronchopulmonary aspergillosis; a review and a report of eight new cases","volume":"7","author":"Hinson KF","year":"1952","unstructured":"Hinson KF, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis; a review and a report of eight new cases. Thorax. 1952, 7:317-333. 10.1136\/thx.7.4.317","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal R","year":"2009","unstructured":"Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009, 135:805-826. 10.1378\/chest.08-2586","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal R","year":"2013","unstructured":"Agarwal R, Chakrabarti A, Shah A, et al.. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013, 43:850-873. 10.1111\/cea.12141","journal-title":"Clin Exp Allergy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.08.007","article-title":"Allergic bronchopulmonary aspergillosis","volume":"2","author":"Greenberger PA","year":"2014","unstructured":"Greenberger PA, Bush RK, Demain JG, Luong A, Slavin RG, Knutsen AP. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2014, 2:703-708. 10.1016\/j.jaip.2014.08.007","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2016.1249853","article-title":"Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis","volume":"10","author":"Agarwal R","year":"2016","unstructured":"Agarwal R, Sehgal IS, Dhooria S, Aggarwal AN. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Rev Respir Med. 2016, 10:1317-1334. 10.1080\/17476348.2016.1249853","journal-title":"Expert Rev Respir Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger PA","year":"2002","unstructured":"Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002, 110:685-692. 10.1067\/mai.2002.130179","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson TF","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, et al.. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 63:1-60. 10.1093\/cid\/ciw326","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher D","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E, et al.. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009, 68:1119-1124. 10.1136\/ard.2008.092163","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature","volume":"122","author":"Li JX","year":"2017","unstructured":"Li JX, Fan LC, Li MH, Cao WJ, Xu JF. Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature. Respir Med. 2017, 122:33-42. 10.1016\/j.rmed.2016.11.019","journal-title":"Respir Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega HG","year":"2014","unstructured":"Ortega HG, Liu MC, Pavord ID, et al.. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014, 371:1198-1207. 10.1056\/NEJMoa1403290","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.01.013","article-title":"Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis","volume":"5","author":"Altman MC","year":"2017","unstructured":"Altman MC, Lenington J, Bronson S, Ayars AG. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2017, 5:1137-1139. 10.1016\/j.jaip.2017.01.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.465","article-title":"Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab","volume":"7","author":"Matsumoto N","year":"2019","unstructured":"Matsumoto N, Shigekusa T, Matsuo A, Tsubouchi H, Yanagi S, Nakazato M. Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab. Respirol Case Rep. 2019, 7:e00465. 10.1002\/rcr2.465","journal-title":"Respirol Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2018.03.004","article-title":"Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"67","author":"Oda N","year":"2018","unstructured":"Oda N, Miyahara N, Senoo S, et al.. Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab. Allergol Int. 2018, 67:521-523. 10.1016\/j.alit.2018.03.004","journal-title":"Allergol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2018.12.008","article-title":"Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab","volume":"68","author":"Soeda S","year":"2019","unstructured":"Soeda S, To M, Kono Y, et al.. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab. Allergol Int. 2019, 68:377-379. 10.1016\/j.alit.2018.12.008","journal-title":"Allergol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2019.100875","article-title":"Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection","volume":"28","author":"Tsubouchi H","year":"2019","unstructured":"Tsubouchi H, Tsuchida S, Yanagi S, et al.. Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection. Respir Med Case Rep. 2019, 28:100875. 10.1016\/j.rmcr.2019.100875","journal-title":"Respir Med Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0617-5","article-title":"A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"18","author":"Terashima T","year":"2018","unstructured":"Terashima T, Shinozaki T, Iwami E, Nakajima T, Matsuzaki T. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab. BMC Pulm Med. 2018, 18:53. 10.1186\/s12890-018-0617-5","journal-title":"BMC Pulm Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2018.11.013","article-title":"Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: case report and review of the literature","volume":"26","author":"Hirota S","year":"2018","unstructured":"Hirota S, Kobayashi Y, Ishiguro T, Nishida T, Kagiyama N, Shimizu Y, Takayanagi N. Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: case report and review of the literature. Respir Med Case Rep. 2018, 26:59-62. 10.1016\/j.rmcr.2018.11.013","journal-title":"Respir Med Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118675","article-title":"T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis","volume":"97","author":"Chauhan B","year":"1996","unstructured":"Chauhan B, Knutsen Ap, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest. 1996, 97:2324-2331. 10.1172\/JCI118675","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.09.005","article-title":"Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis","volume":"104","author":"Agarwal R","year":"2010","unstructured":"Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Saikia B, Chakrabarti A, Jindal S. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med. 2010, 104:204-210. 10.1016\/j.rmed.2009.09.005","journal-title":"Respir Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal R","year":"2016","unstructured":"Agarwal R, Aggarwal AN, Dhooria S, et al.. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2016, 47:490-498. 10.1183\/13993003.01475-2015","journal-title":"Eur Respir J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-5_part_1-200309020-00012","article-title":"How do corticosteroids work in asthma?","volume":"139","author":"Barnes PJ","year":"2003","unstructured":"Barnes PJ, Adcock IM. How do corticosteroids work in asthma?. Ann Intern Med. 2003, 139:359-370. 10.7326\/0003-4819-139-5_part_1-200309020-00012","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.10.026","article-title":"In response to dosing omalizumab in allergic asthma","volume":"119","author":"Jaffe JS","year":"2007","unstructured":"Jaffe JS, Massanari M. In response to dosing omalizumab in allergic asthma. J Allergy Clin Immunol. 2007, 119:255-256. 10.1016\/j.jaci.2006.10.026","journal-title":"J Allergy Clin Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1382","article-title":"Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics","volume":"111","author":"Menzies-Gow A","year":"2003","unstructured":"Menzies-Gow A, Flood-Page P, Sehmi R, et al.. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol. 2003, 111:714-719. 10.1067\/mai.2003.1382","journal-title":"J Allergy Clin Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.08.037","article-title":"New childhood and adult reference intervals for total IgE","volume":"133","author":"Martins TB","year":"2014","unstructured":"Martins TB, Bandhauer ME, Bunker AM, Roberts WL, Hill HR. New childhood and adult reference intervals for total IgE. J Allergy Clin Immunol. 2014, 133:589-591. 10.1016\/j.jaci.2013.08.037","journal-title":"J Allergy Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0952-1","article-title":"Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis","volume":"19","author":"Numata T","year":"2019","unstructured":"Numata T, Nakayama K, Utsumi H, et al.. Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis. BMC Pulm Med. 2019, 19:176. 10.1186\/s12890-019-0952-1","journal-title":"BMC Pulm Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02346","article-title":"Allergic bronchopulmonary aspergillosis-a luminal hypereosinophilic disease with extracellular trap cell death","volume":"9","author":"Ueki S","year":"2018","unstructured":"Ueki S, Hebisawa A, Kitani M, Asano K, Neves JS. Allergic bronchopulmonary aspergillosis-a luminal hypereosinophilic disease with extracellular trap cell death. Front Immunol. 2018, 9:2346. 10.3389\/fimmu.2018.02346","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37420-mepolizumab-as-possible-treatment-for-allergic-bronchopulmonary-aspergillosis-a-review-of-eight-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:20:35Z","timestamp":1707506435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37420-mepolizumab-as-possible-treatment-for-allergic-bronchopulmonary-aspergillosis-a-review-of-eight-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.9684","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,12]]}}}